Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05735119 · ClinicalTrials.gov registry record
Embody Post-Market Clinical Follow-Up Study
A clinical trial, sponsored by Zimmer Biomet.
- Active
- Registry status
- 100
- Enrollment target
NCT05735119 is a clinical trial that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 100 participants.
The verdict
NCT05735119 is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
A multi-center, prospective post-market clinical follow-up study: subscapularis repair augmented with Tapestry Biointegrative Implant after shoulder arthroplasty. The primary objective of this study is to evaluate the long-term integrity of the subscapularis tendon repair after shoulder arthroplasty augmented with Tapestry Biointegrative Implant, assessed by ultrasound 6 months postoperatively. Secondary objectives are to assess shoulder function (internal rotation strength), safety, and patient reported outcomes. Patients will be evaluated preoperatively, at the time of surgery, 3, 6, 12 and 24 months after surgery.
Interventions
- DEVICE Tapestry Biointegrative Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-11-09 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05735119
The ClinicalTrials.gov registry entry for NCT05735119 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tapestry Biointegrative Implant is the first listed.
NCT05735119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05735119 about?
NCT05735119 is a clinical study titled "Embody Post-Market Clinical Follow-Up Study". A multi-center, prospective post-market clinical follow-up study: subscapularis repair augmented with Tapestry Biointegrative Implant after shoulder arthroplasty. The primary objective of this study is to evaluate the long-term integrity of the subscapularis tendon repair after shoulder arthroplasty...
What is the current status of trial NCT05735119?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2022-11-09. Estimated completion is 2028-06.
What interventions are being tested in trial NCT05735119?
The interventions under investigation include: Tapestry Biointegrative Implant (DEVICE).
Who is sponsoring clinical trial NCT05735119?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.